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ABSTRACT 
 
 
zf35 is a mutation in the unc-2 gene of C. elegans that causes a hyperactive 
phenotype.  unc-2 encodes the alpha-1a subunit of a P/Q type calcium channel involved 
in synaptic transmission in C. elegans. Double mutants were constructed of zf35 and 
known synaptic transmission mutants egl-30, unc-13, snt-1, and unc-31, to determine 
how zf35 affects neurotransmitter release. Also, a genetic screen was done to identify 
mutations that suppress the zf35 phenotype, revealing novel genes in this pathway.  We 
conclude that zf35 mutants have defects in the presynaptic pathway.  
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BACKGROUND 
 
C. elegans as an Animal Model 
The nematode Caenorhabditis elegans is a highly useful model for genetic 
research. This organism can conveniently be grown in vitro on OP50 E. coli spotted on 
agar plates.  C. elegans grows rapidly, has its complete genome sequenced, has a short 
life cycle, has short clearly defined stages of development, is easily available, and its 
research is relevant to higher level organisms. Having only 6 total chromosomes, namely 
1, 2, 3, 4, 5, and X, has helped biologists understand its genes in more detail.  
C. elegans has two sexes: male or hermaphrodite.  Hermaphrodites have two sex 
chromosomes (XX) while the males have one sex chromosome (X0).  Hermaphrodites 
can self propagate and lay eggs, or they can mate with males. The life cycle of C. elegans 
is important in research especially when setting up crosses. C. elegans has 4 larval stages 
consisting of L1, L2, L3, and the L4 stage. The L4 stage is an important stage for 
distinguishing phenotypes, staging strains, mating, and is easily distinguished by a white 
crescent in the vulval region of the worm. After the larval stages, C. elegans develops 
into young adults and eventually adults. The entire life cycle is shown in figure 1 (Altun 
and Hall, 2006). 
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Figure 1: The C. elegans Life Cycle.  Shows the complete life cycle of the C. elegans worm from egg to 
adult.  Major stages include egg, L1, L2, L3, L4, young adult, and adult (Altun and Hall, 2006). 
 
 Research with C. elegans includes studying apoptosis, inter/intracellular 
signaling, parasitic interactions, and neuronal growth. The implications of C. elegans 
research in vertebrate neuronal growth and function is important because this work helps 
better understand human neuronal growth and function (Chou et al., 2008). C. elegans 
has proven to be an important asset in neurobiology. For behavioral research, C. elegans 
shows a large variety of behaviors including locomotion, foraging, feeding, defecation, 
egg laying, dauer larvae formation, and responses to touch, smell, taste and temperature. 
More intricate behaviors include male mating, social behavior, learning and memory 
(Altun and Hall, 2006). Thus, the study of how neurons interact and the responses by the 
body can easily be studied using C. elegans. 
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Green fluorescent protein (GFP) is a widely used reporter protein that has been 
used as a genetic marker in C. elegans. The transparency of C. elegans makes it amenable 
for viewing GFP, as the worms can be viewed microscopically without dissection. 
Transgenic strains can be established using germ line transformation (Boulin et al., 
2006).   
Another advantage of C. elegans in genetic analysis is reverse genetics can be 
used to characterize genes. Reverse genetics is initiated with the study of the genomic 
sequences. Using mutagenesis techniques such as EMS, gene sequences are randomly 
changed, and the resulting phenotype is analyzed. The advantages of reverse genetics 
include the ability to analyze all the genes in a gene family, analyze the function of 
homologous genes in other organisms, and study abundant genes that are still unaltered. 
Many of these goals cannot be achieved using forward genetics (Ahringer, 2006).  
 
C. elegans Nervous System 
The C. elegans nervous system is compromised of only 302 neurons (Nonet et al., 
2008). The organization of the C. elegans nervous system consists of ganglia in the head 
and the tail. There are also smaller ganglia and scattered neurons positioned throughout 
the body. The processes of all neurons project to the nerve ring inside the head as seen in 
figure 2 (Altun and Hall, 2006). 
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Figure 2: Key Features of the C. elegans Nervous System. Highlighted above are the major features of 
the C. elegans nervous system and its organization (Altun and Hall, 2006). 
 
There are two main strains of wild-type C. elegans used in labs today: the N2 or 
Bristol strain, and the CB4856 or Hawaiian strain. These two strains were geographically 
separated for so long that millions of years of genetic drift caused polymorphisms in the 
DNA between the two strains. On average, these differences occur every 1000 base pairs, 
primarily in the non-coding regions of the genetic code, and cause no observed functional 
changes between the two strains (Jakubowski and Kornfeld, 1999; Koch et al., 2000; 
Wicks et al., 2001; Swan et al., 2002). A few rare changes may affect protein activity and 
gene expression resulting in varying mating behavior as well as varying responses to 
interference RNA (Tijsternman et al., 2002). 
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Synaptic Transmission  
 Synaptic transmission is a complex series of events that happen in sequence that 
result in relaying an electrical signal from the presynaptic neuron to the post-synaptic 
neuron.  This process involves the conversion of an electrical impulse, the action 
potential, to the chemical signal of a neurotransmitter. The synapse can carry a vast array 
of signals. The specificity of these signals depends on where the signal originated, where 
the signal is going, the neurotransmitter used, and its mechanism of action.  
 There are some major steps required for synaptic transmission that should be 
mentioned (Finlay and Markha, 1997). Neurotransmitters are chemicals produced in a 
presynaptic axon terminal that act as the main messenger and signaling molecules of the 
nervous system. Once secreted from the presynaptic neuron into the synaptic space, they 
act upon the postsynaptic neuron by binding specific sets of receptors. Some examples of 
neurotransmitters include acetylcholine, serotonin, and dopamine. Neurotransmitters are 
stored inside vesicles in the axon terminal of the presynaptic neuron. Once an action 
potential comes down from an axon to the axon terminal, calcium channels open and let 
calcium in. This influx of calcium signals the presynaptic vesicles to release the 
neurotransmitter into the synaptic cleft. This process requires the presynaptic vesicles to 
dock at the axon terminal and to sense changes in calcium. During release, the 
neurotransmitter molecules travel by the process of diffusion towards the postsynaptic 
neuron where they bind to receptors to initiate ion flow across the post-synaptic 
membrane. In many cases another action potential is initiated by the influx of sodium 
ions (Finlay and Markha, 1997). 
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Once a neurotransmitter has bound its receptor, it must stop its signal or risk an 
undesired effect on the postsynaptic neuron. This inhibition is provided by the process of 
degradation of the neurotransmitter by an enzyme (in the case of acetylcholine this 
enzyme is acetylcholine esterase) or reuptake by the presynaptic neuron or glia. In the 
case of uptake, vesicles are reformed around the neurotransmitter.  The vesicles then wait 
for the next action potential to induce another synaptic transmission (Finlay and Markha, 
1997). 
 
Acetylcholine Neurotransmitter 
Acetylcholine is one of the major excitatory neurotransmitters of the nervous 
system.  It was the first neurotransmitter ever discovered in 1955 by Helen Mellanby. 
Acetylcholine also acts as a major excitatory neurotransmitter in nematodes, over 1/3 of 
all cells in the C. elegans nervous system secrete it at the neuromuscular junction for a 
variety of purposes, including movement, feeding, male mating, and egg laying.  
Relative to the topic of this MQP, it is important to examine cholinergic 
neurotransmission to better understand how acetylcholine works as a neurotransmitter.  
Acetylcholine is created by an enzyme called choline acetyltransferase (Rand, 2007).  
After being synthesized, the vesicular acetylcholine transporter loads acetylcholine into 
synaptic vesicles. As mentioned before, synaptic vesicles are used to store the 
acetylcholine until an action potential arrives at the axon terminal. This vesicular 
acetylcholine transporter is driven by a proton gradient that exists between the cytoplasm 
of the neuron and the synaptic vesicle. As seen in figure 3, the vesicular acetylcholine 
transporter is unc-17 (uncoordinated) (Rand, 2007). 
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Figure 3: The Mechanism of Acetylcholine Formation and Breakdown. Shows the full cycle of 
acetylcholine from its formation, release, breakdown, reuptake, and reformation (Rand, 2007). 
 
The vesicular acetylcholine transporter uses an anti-port system in which one 
proton is exported from the synaptic vesicle while one acetylcholine molecule is pumped 
into the synaptic vesicle. For this to be possible, the concentration of protons outside the 
synaptic vesicle has to be less than within the vesicle, or the internal pH of the vesicle has 
to be higher than the cytoplasm of the neuron (Rand, 2007). 
Vesicle Docking to the Membrane 
Once the acetylcholine has been inserted into the synaptic vesicles, a series of 
steps occur that result in the vesicle docking to the neuronal membrane and releasing 
acetylcholine into the synaptic cleft. The cycle that a synaptic vesicle goes through is 
diagramed in figure 4 (Rand, 2007). 
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Figure 4: The Synaptic Vesicle Cycle. Diagramed are the important steps in the vesicle life cycle, 
including its function as transporter of acetylcholine neurotransmitter (Rand, 2007). 
 
 
The mechanism of vesicle docking has been a hotly debated research topic. It has 
been shown that synaptic vesicles dock near active zones through molecular recognition. 
Various SNARE proteins and receptors are involved in docking. The SNARE 
synaptobrevin is encoded by the gene snb-1 in C. elegans.  This protein is located on the 
vesicle itself during docking. Syntaxin (encoded by unc-64) and SNAP-25 (encoded by 
ric-4) are on the plasma membrane. All of these together make the docking complex in C. 
elegans. Rab3 GTPase is also a co-factor to various proteins in the “active zone” on the 
plasma membrane. One of the proteins Rab3 acts with Rim, encoded by unc-10. unc-10 is 
also known to play a role in priming (see below).  A study of the unc-18 mutant has 
revealed a protein family named SM and its importance in docking. SM proteins interact 
with syntaxins. However, the mechanism of action of SM’s role in vesicle docking is still 
unknown (Rand, 2007). 
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Vesicle Priming  
After vesicle docking to the membrane is complete, the vesicle now has to be 
directed and primed for fusion. SNAREs such as syntaxin and SNAP-25 located on the 
plasma membrane and synaptobrevin in the vesicle membrane start forming complexes 
that move the vesicle in proximity to the plasma membrane. The unc-13 mutant has been 
implicated as an important priming factor. The protein Rim has been shown to play a 
complementary role in vesicle priming. Rim has been characterized by the unc-10 
mutant. Rim’s exact purpose is still speculative (Rand, 2007). 
 
Ca2+ Sensing  
 Once the vesicle has been primed for fusion, fusion to the membrane occurs only 
when calcium levels in the nerve terminal rises. The calcium sensing in the presynaptic 
terminal is centered on the voltage-gated calcium channels which contain the UNC-2 α1 
subunit.  Other channels may also contribute to calcium sensing, such as unc-36, egl-19 
(egg laying deficient), and unc-68. Synaptotagmin, encoded by snt-1, is a vesicle 
associated protein that has been implicated as a calcium-sensor in exocytosis as well as 
an AP-2 binding partner in endocytosis.  AP-2 is a clathrin adaptor that plays a major role 
in fission, uncoating, and sorting of vesicles (Rand, 2007).  
  
 Vesicle Fusion  
Once calcium has entered the axon terminal, the vesicles that were primed and 
docked fuse with the plasma membrane. Neurotransmitter held in this vesicle is then 
released into the synaptic cleft. SNARE proteins, syntaxin, SNAP
all play a role in vesicle fusion. A SNARE complex forms, bringing the vesicle in close 
proximity to the plasma membrane where fusion occurs with Ca
Once acetylcholine has been released into the synaptic cleft, it 
cleft and activates acetylcholine receptors 
cleared from the synapse by the enzyme acetyl
2007). Acetylcholinesterase hydrolyzes acetylcholine by 
and choline. 
Figure 5: Acetylcholine Hydrolysis.  The above reaction is mediated by the enzyme acetylcholinesterase
that catalyzes the reaction in which acetylcholine is broken down to choline and acetic acid 
(Cholinesterase, 2008). 
 
Once acetylcholine is broken down, the choline byproduct is taken back up into 
the presynaptic neuron by a high affinity choline transporter. Choline can then be 
reconverted into acetylcholine by choline acetyltransferase. After fusion, vesic
14
-25, and synaptobrevin 
2+
 influx (Rand, 2007).
diffuses across the 
on the post-synaptic cell. Acetylcholine is 
cholinesterase shown on figure 5 (Rand, 
breaking it down into acetic acid 
 
le proteins 
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and membrane fragments are reorganized into synaptic vesicles for more exocytosis. It 
should be noted that the vesicles are also involved in transporting back the choline that is 
floating in the synaptic cleft so transmission can continue (Rand, 2007). 
 
UNC-2 
The Ca2+ channel alpha subunit encoded by the unc-2 gene is involved in proper 
muscle contraction and speed in movement as shown in figure 6. UNC-2 is homologous 
to the human calcium channel, CACNA1A, which has been associated with Familial 
Hemiplegic Migraine. Calcium channels are composed of α1, α2, β, and δ subunits. The α1 
subunit is the most important functional component of the Ca2+ channel, as it forms the 
voltage sensor and the ion-conducting pore. The human gene responsible for the effects 
of   FHM-1is CACNL1A4, which encodes the brain-specific P/Q type Ca2+ channel α1 
subunit (Ophoff et al., 1996).  
In C. elegans, the unc-2 gene is expressed in sensory, motor, VC (Ventral Cord), 
and HSN (Hermaphrodite Specific Neuron) neurons. The HSN and VC neurons control 
the egg laying and other motor functions in C. elegans (WormBase, 2008). 
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Figure 6: Role of unc-2 and the Calcium Channel.  Diagram shows the role of the calcium channel, one 
subunit is encoded by unc-2 (Pirri & Alkema, Personal Communication). 
 
 
The zf35 Mutant 
The zf35 mutant was originally isolated in a genetic screen of C. elegans with 
previous defects in the unc-2 gene. unc-2 animals are uncoordinated, while the zf35 
mutant animals showed a higher reversal rate to a coordinated phenotype compared to 
wild-type. Also, zf35 worms fail to suppress head oscillations in response to touch. Figure 
7 shows the hyper-reversal and hyper-active egg laying behavior of the zf35 mutant 
compared to wild-type (Pirri & Alkema, Personal Communication). 
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Figure 7: Effects of zf35 Mutant on Egg Laying and Phenotype Reversals.  zf35 is hyperactive in egg 
laying, showing a decreased number of eggs in the uterus (increased number laid), and has the phenotype 
hyper -reversal characteristic compared to the wild-type. In a phenotype reversal, a previously 
uncoordinated worm now coordinately moves backwards in response to a prodding (Pirri & Alkema, 
Personal Communication). 
 
goa-1 and zf35 worms are hyperactive in egg laying. The goa-1 is a mutant 
hyperactive in acetylcholine release. This is a loss of function mutation involved in the 
Gα0 pathway.  zf35, on the other hand, is a gain of function mutation in the unc-2 gene. 
Figure 8 shows the hyperactive egg laying characteristic of goa-1 mutant compared to the 
wild-type (Bastiani & Mendel, 2006). 
 
Figure 8: The goa-1 Mutant is Hyperactive for Egg Laying. Goa-1 (lower panel) is hyperactive in egg 
laying like zf35 (fewer eggs present in the gonad), while wild-type animals (upper panel) retain fertilized 
eggs longer (for ~2.5 hours) before laying them (Bany et al., 2003). 
 
 Aldicarb and Levamisole 
Aldicarb and levamisole ar
be used to determine pre vs. post-synaptic cholinergic signaling. Aldicarb is an 
acetylcholine esterase inhibitor (figure 9)
prevent excessive and prolonged acetylcholine signaling. Without acetylcholinesterase 
there is a buildup of acetylcholine in the synaptic cleft resulting in hyper contraction, 
paralysis, etc. Defects in cholinergi
aldicarb assay. Mutants that are resistant to aldicarb would move 
type worms have become paralyzed. Mutants that are hypersensitive to aldicarb would 
become paralyzed sooner than wild
hypersensitive mutant to aldicarb would indicate that too much acetylcholine is being 
produced or not enough acetylcholine is being degraded. To facilitate the aldicarb assay, 
a levamisole assay further narrows down the biochemical cause of the phenotype 
(Mahoney et. al., 2006). 
Figure 9: Aldicarb Mechanism. Aldicarb blocks the action of acetylcholine esterase and thus 
acetylcholine remains bound to the receptor longer eventually causing paralysis 
Communication). 
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e drugs relevant to the cholinergic pathway.  They can 
. The purpose of acetylcholinesterase is to 
c signaling in C. elegans can be characterized with an 
normally while wild
-type worms if placed on an aldicarb plate. A 
 
(Pirri & Alkema, Personal 
-
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 Levamisole is a drug originally used as an antibiotic, pesticide, and cancer 
medication, and is a cholinergic agonist. Levamisole amplifies the effects of 
acetylcholine by activating acetylcholine receptors in a non-competitive allosteric 
manner.  Assays using levamisole test whether there are too many receptors at the post 
synaptic level or too little. Levamisole assays also test for functional receptors. The 
amplified number or function of receptors of a C. elegans strain can be implied by 
sensitivity to levamisole relative to wild-type.  Resistance to levamisole may suggest that 
the function or number of receptors in a C. elegans strain is less than wild-type (Lewis et 
al., 1980).  Hence, aldicarb assays combined with levamisole assays are an excellent 
method of predicting whether the biochemistry of the mutation is taking place 
postsynaptically or presynaptically. 
  
 20
 
PROJECT PURPOSE 
 
The purpose of this project was to determine how the zf35 mutation affects 
synaptic transmission. The zf35 mutation was originally identified as an allele of the unc-
2 gene. We performed epistatic analysis by building double mutants of known synaptic 
transmission mutants, such as egl-30, unc-13, snt-1,and unc-31. The resulting phenotypes 
of the double mutants were studied and compared with both zf35 and wild-type to dissect 
the genetic pathway and study gene interactions. The goal of these experiments was to 
determine how unc-2 (zf35) affects neurotransmitter release. Finally, a genetic screen was 
done to find the mutations that suppress the unc-2 (zf35) phenotype, hopefully revealing 
novel genes in this pathway. 
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METHODS 
 
Isolation of Plasmid DNA and Sequencing  
Isolation of plasmid DNA was performed using the QIA prep Spin Miniprep Kit 
Protocol.  Sequencing was performed by an offsite company (GeneWiz).  
EMS Mutagenesis  
 Plates of zf35 L4 larvae were washed with M9 (Na2HPO4, KH2PO4, NaCl, NH4Cl, 
dH2O) using sterile glass pipettes. The worms were transferred to a 15 ml sterile plastic 
centrifuge tube and centrifuged at 1000 rpm for 30 sec. The supernatant was removed and 
the worms were washed twice with M9 before being suspended in a final volume of 3 ml. 
Next, 20 µl of EMS (methanesulfonic acid, ethyl ester, Sigma #M-0880) was added to 1 
ml of M9 in a separate 15 ml tube under the hood. The EMS suspension was mixed until 
it was no longer cloudy.  Next, 3 ml of zf35 worms were transferred into the tube of 
EMS. The top of the tube was parafilmed and placed on a spinning wheel at 20° for 4 
hours. After 4 hours, the worms were centrifuged and the supernatant was removed. The 
worms were then washed twice with ~3 ml of M9, and transferred in a few drops of M9, 
using a sterile glass pipette, to a plate seeded with OP50 E. coli.  
F2 Mutant Screen 
 After EMS treatment, the worms were left on the plates to recover for 15-20 
minutes, and then healthy looking late L4 animals were picked off and placed on new 
plates, and allowed to recover for 24 hours.  3-4 gravid adult P0 worms were put on 60 90 
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mm plates, and allowed to lay eggs for 4 hours. The 4 P0 worms per plate laid an average 
of 70 eggs after 4 hours, resulting in ~70 F1 progeny per plate. The F1 animals were 
removed from the plate after they laid the F2 eggs. The F1 animals were washed off the 
plate by gently swirling the plate after adding M9, and then pouring the M9 off the plate. 
This removes most of the adults remaining, leaving the eggs behind.  The remaining F1 
worms were sucked off the plate using a pasteur pipette hooked up to a vacuum line 
under the dissecting scope with a 12X objective. Once the EMS mutagenesis was 
complete, the worms from the F2 generation were placed on 9 cm NGM (NaCl, Bacto-
Agar, Peptone, H2O, 1M CaCl2, 5 mg/ml cholesterol in EtOH, 1M MgSO4, 1M KPO4 
buffer) agar aldicarb plates. After 1 hour, worms that showed movement were picked and 
singled to small NGM agar plates.  
Aldicarb and Levamisole Assays  
  Aldicarb and levamisole assays were used to monitor the sensitivity of C. elegans 
to the paralyzing effects of these drugs. The worms were assayed on NGM agar 
containing 1mM aldicarb or 100 µM levamisole seeded with OP50 E. coli. About 16-24 
hours before the assay was performed, L4 larval stage worms of each genotype were 
picked onto a fresh NGM plate containing OP50 E. coli.  Twenty young adult worms 
were transferred to each aldicarb and levamisole plate at the start of the assay. Other C. 
elegans strains such as wild-type and zf35 were also assayed as controls. The worms were 
checked every 15 minutes for paralysis. A worm was defined as paralyzed if there was no 
movement when prodded three times with a platinum wire on the head and tail. The 
worms were scored until all of the worms paralyzed or if the majority of the worms were 
not paralyzed within 3 hours.  
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 The following information was used to analyze the results of the aldicarb and 
levamisole assays. Mutant worms with a block in acetylcholine release are generally 
aldicarb resistant, and worms with enhanced acetylcholine release are aldicarb 
hypersensitive. Aldicarb assays alone cannot determine if a mutant worm has pre or 
postsynaptic defects since a mutation in a postsynaptic cholinergic receptor can cause 
resistance to aldicarb. The resistance to aldicarb is caused by a decrease in the number of 
functional receptors. Levamisole activates acetylcholine receptors which act in 
postsynaptic cells. Worms with mutations in presynaptic genes generally show a similar 
rate of paralysis as wild-type worms. However, mutations in post-synaptic genes result in 
levamisole resistance. Aldicarb resistance and levamisole sensitivity suggests defects in 
synaptic release (presynapse). Aldicarb resistance and levamisole resistance suggests 
postsynaptic defects. 
Preparation of C. elegans Culture Lysates  
 The worm lysates were prepared by first picking worms into 1X Lysis buffer 
placed 0.2 ml PCR tubes (1 µl of 1X Lysis buffer was used per worm).  After the worms 
were picked into the lysis buffer, the PCR tubes with the worms in solution were frozen 
at –20°C overnight, or at -80°C for about an hour. The worms were then lysed at 65°C for 
1 hour and at 95°C for 15 min in an Eppendorf Thermalcycler. 
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Polymerase Chain Reaction (PCR)  
 For the PCR, 10.0 µL master mix containing  1 µl of 10X PCR Buffer , 1 µl of 2 
mM dNTPs, 1 µl of DNA (worm lysate), 0.1 µl of Taq (WoostaQ), 0.5 µL of 10 µM 
forward primer,  0.5 µL of  10 µM reverse primer, and 5.9 µL of dH2O were made for 
each reaction. The sample was then placed in the thermalcycler and heated at 94°C for 2 
minutes. Next, 35 cycles of the following temperatures and times were conducted: 94°C 
for 15 seconds, 60°C for 45 seconds, and 72°C for 1 minute. Next, a 5 minute 72°C step 
was performed.  Following this reaction, 4 µl of 5X orange G loading buffer was added 
to each reaction. Finally, 14 µl of each reaction was run on a 1.0 % agarose gel at 150V 
for 40-45 minutes. 
SNP Mapping   
 
SNPs or small nuclear polymorphisms are single base changes. Recognition sites 
are created using SNPs for endonucleases, which cleave phosphodiester bonds internally 
within a sequence of DNA. Because of the divergent evolution of C. elegans resulting in 
the N2 and CB4856 strains, there are a number of differences in the genetic code 
occurring about every 1000 base pairs. These changes are DNA polymorphisms which 
are used in SNP mapping to locate mutations to specific chromosomes. Furthermore, 
SNPs that have the length of a restriction fragment (RFLPs) are preferred because 
restriction enzymes can then be used. The cleavage resulting from restriction enzymes 
can occur in either the N2 fragments or the CB4856 fragments. The differentiation of the 
isolates is more important than the specificity of the differentiation. The two major 
advantages of SNP mapping are cloning of a wide variety of mutations, and narrowing 
down the locus of mutations within 30,000 base pairs or 6-7 genes (Fay & Bender, 2008). 
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 SNP mapping was used to determine the identity of the zf35 mutation. SNP 
mapping uses DNA sequence polymorphisms between the N2-Bristol and CB4856-
Hawaiian strain of C. elegans as genetic markers (Davis et al. 2005).  The DNA was 
isolated from the mutants by setting up the following cross. The zf35 hermaphrodites 
were mated with CB4856 males. Then 8-10 non-mutant (F1 zf35/+ hermaphrodites) 
worms were picked to single plates and they were left to self-fertilize. Then ~50 (F2 
zf35/zf35 hermaphrodites) worms showing the mutation were picked to single plates. The 
F2 worms were then left to self-fertilize. The plates were then checked to see that each 
plate population is homozygous for the mutation. From each of the 50 plates, 50 worms 
were picked to make lysates. To determine the chromosome on which the mutation lies, 4 
µl of lysate from each of the 50 tubes was pooled into a 1.5 ml tube.  Figure 10 shows the 
total of 8 SNP primer pairs per chromosome that were used for each chromosome 
mapping.  
 26
  
Figure 10: DraI SNPs in N2-Bristol and CB4856-Hawaiian (Davis et al., 2005). 
 
The reaction was set up in a 96-well plate consisting of the mutation mix and an 
N2/CB4856 control against all 8 pairs of SNPs on all 6 chromosomes (48 wells for each). 
Figure 11 shows the setup used.  
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 Figure 11a: Chromosome Mapping 96-well Plate (McPherson & Alkema, Personal Communication). 
 
 
To set up the PCR reaction, two separate 50 reaction master mixes were made, 
one for the mutant lysates and one for the N2/CB4856 control. The master mix for 50 
reactions consisted of 50 µl of 10X PCR Buffer, 50 µl of 2mM dNTPs, 50 µl of pooled 
lysate (25 µl N2 &  25µl CB), 5 µl of Taq (WoostaQ), and 299 µL of dH2O. After both 
the master mixes were made, 9 µl of the master mix was added to each of the 48 mutant 
wells, and 9 µl of the control mix was added to each of the 48 control wells. Then 1 µl of 
the 10 µM primer pairs made from the clones shown on figure 10 were added with a pin 
replicator since the stock solutions of the 10 µM primer pairs were also stored in 96 well 
plates in the same orientation as the table above. The plate was sealed with a mat, and the 
PCR reaction was run under the conditions listed under the PCR protocol.  
The digest for the chromosome mapping was then prepared. The restriction 
enzyme, DraI was used for chromosome mapping. The reagents for 1 reaction included 
1.6 µl of 10X buffer, 0.1 µl of DraI, and 4.3 µl of dH2O.  A total of 100 reactions of the 
DraI cocktail were prepared, and 6 µl was added to each well using a multichannel pipet. 
The PCR products were digested overnight for 12-15 hrs at 37°C. After ~12 hours, 4 µl 
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of 5X orange G loading buffer was added to each well, and 15 µl from each well was 
loaded onto a 2.0% agarose gel as shown in figure 11b.  
 
Figure 11b: Loading a SNP Gel (McPherson & Alkema, Personal Communication). 
 
The samples were run at 150V for 40-45 minutes. The following criteria were 
used to interpret the results. If there is no linkage, then the lanes with the mutant DNA 
should look identical in band position and intensity as the 50:50 N2/CB4856 mix. 
However, if there is linkage to a chromosome then the N2 band should be enriched (much 
more intense) and CB4856 should be decreased in comparison to the N2/CB4856 mix. If 
the mutation is located closer to the SNP being tested, there is more chance for an 
enhancement of the N2 DNA to be seen in a homozygous mutant and a lesser chance of a 
recombination event taking place. Consequently, there is a lesser chance for the CB4856 
allele to be observed in a homozygous mutant as the mutation gets closer to the SNP 
tested. Furthermore, if the SNP and the mutation are in very close proximity to each 
other, only the N2 band may appear for the homozygous mutants that are located at this 
SNP. 
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Complementation Test 
Complementation tests are crosses where an unknown mutant strain is crossed 
with a strain carrying a known mutation.  The progeny of this cross is then analyzed for a 
distribution of 50% wild type and 50 % mutant, or 100% wild type.  If the former case 
occurs where one-half of the progeny shows the mutant phenotype and the other half 
shows the wild-type phenotype, then the unknown strain is considered the same as the 
known mutant. Half the progeny of the F1 generation should have the genotype 

 
while the other half should have the genotype  
	
 
.  If the unknown mutation is the 
same as the known mutant, the mutant phenotype should appear for the  

 
genotype.  If the unknown strain is not the mutant, then a wild-type phenotype should 
appear for the 

 genotype so the progeny are wild-type. Figure 12 shows the cross 
that was setup for the complementation tests. 
 
Figure 12: The Complementation Test.  Note that the lon-2 gene is marker for the long phenotype. 
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RESULTS 
 
 
The main goal of this project was to characterize the zf35 mutant by identifying 
the gene causing the hyperactive phenotype and performing epistatic analysis using 
double mutants in order to support the hypothesis that the zf35 mutant had defects in the 
presynaptic pathway. Furthermore, an EMS suppressor screen with a zf35;lon-2 
background was done to provide novel mutations for further analysis. The 
characterization of zf35 began by performing aldicarb and levamisole assays on the wild-
type and zf35. 
 
Aldicarb & Levamisole Assays 
 The N2 (WT) and zf35 strains were shown to have different sensitivities to 1mM 
aldicarb. Aldicarb is an acetylcholine esterase inhibitor, which causes an increase of 
acetylcholine. This leads to eventual hyper-contraction at the synapse and paralysis. 
Figure 13 shows the time course aldicarb sensitivity assay of the N2 and zf35 strains.  
The zf35 mutant paralyzes earlier than N2 WT, suggesting that the mutation could 
act presynaptically by causing the release of more acetylcholine into the synaptic cleft 
than the wild-type strain. Alternatively, there could be a problem with the choline 
reuptake mechanism, as well as the reassembly of choline and acetyl CoA into 
acetylcholine by the enzyme choline acetyltransferase. Another possible scenario could 
be that the zf35 sensitivity to aldicarb may be caused by an increase in the number of 
functional receptors. Hence, to fully understand where in synaptic transmission the zf35 
mutation acts, we performed levamisole assays to complement the aldicarb assays. 
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Figure 13: N2 and zf35 Aldicarb Assay. zf35 (red curve) is more sensitive to aldicarb than N2 WT (blue 
curve) as indicated by early paralysis. 
 
 
Levamisole assays were performed on the N2 and zf35 strains to determine if 
there were postsynaptic defects in the zf35 mutants. Figure 14 shows the time course of 
the levamisole sensitivity assay. Based on this data, it was determined that the N2 wild 
type and the zf35 mutant showed a similar sensitivity to levamisole. This indicates that 
zf35 did not alter the post-synaptic function of acetylcholine release. Thus, analysis of 
zf35 using aldicarb and levamisole suggests that the gene containing the zf35 mutation 
functions presynaptically. 
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Figure 14: N2 & zf35 Levamisole Assay.  zf35 and N2 (WT) have a similar rate of paralysis in the 
presence of Levamisole. 
 
Chromosome SNP mapping was used to determine the locus of zf35. This work 
was initiated by Pirri and Alkema, and extended in this project.  As shown in figure 15, 
evidence of the strongest linkage was observed in chromosome X (Pirri & Alkema, 
Personal Communication). This area of linkage is highlighted by the dotted red box in 
figure 15.   
 
Figure 15: SNP mapping of zf35.  The red box (chromosome X) indicates the locus where strongest 
linkage is observed (Pirri & Alkema, Personal Communication). 
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Fine mapping was performed to further narrow down the interval on the X 
chromosome where zf35 might be located.  In order to do this, recombinants were made 
by crossing the zf35 strain with dpy-3; lon-2. Figure 16 shows the results from the fine 
mapping using the recombinants. The mutation was mapped to a small interval of 1.18 
centimorgans, -14.02 to -13.2 on chromosome X.  Recombinants are used in fine 
mapping to facilitate recombination events. The closer one gets to the mutation, the lesser 
the chance of recombination exists (Pirri & Alkema, Personal Communication). 
 
Figure 16: Unc-2 Fine Mapping.  unc-2 was fine mapped to the interval of -14.02 and -13.02 (Pirri & 
Alkema, Personal Communication). 
 
Figure 17 shows the 8 genes known to exist in this region. Researching each of 
these genes revealed that unc-2 was the only plausible gene that fit the presynaptic 
characterization determined by previous experiments.  The α1 subunit that unc-2 
(uncoordinated) encodes in the calcium channel is involved in the proper muscle 
contraction and speed in movement. This channel is homologous to the mammalian 
calcium channel, CACNA1A. This neuronal calcium channel is used for regular release 
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of neurotransmitters from the axon terminal. Therefore, disruption of this voltage gated 
calcium channel may cause abnormal release of acetylcholine into the synaptic cleft. 
 
 
Figure 17: The 8 Known Genes Located on Chromosome I Between -14.02 and -13.2. 
 
Double Mutants  
Epistatic analysis of the double mutants was used to determine where in the 
synaptic release pathway zf35 acts. Double mutants of zf35 with various known 
presynaptic mutants were created and assayed. The cross used to construct these double 
mutants can be seen in figure 18. The double mutants egl-30; zf35, unc-13; zf35, snt-1; 
zf35, and unc-31; zf35 were constructed to look for interactions between genes. Possible 
suppression was observed in the egl-30; zf35, unc-13; zf35, and snt-1; zf35 double 
mutants based on aldicarb assays and the resulting visible phenotypes.  
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Figure 18: Cross Scheme for Formation of Double Mutants With zf35. unc-64, unc-13, unc-31, snt-1 & 
egl-30 were chosen because of their known role in presynaptic function. 
 
Aldicarb assays were performed on each of these double mutants (Figure 19). 
These assays are displayed in graph form with N2, and the zf35 single mutant serving as 
controls. snt-1 worms show abnormal pharyngeal pumping as well as jerky backward 
movements. snt-1 is also a partial loss of function, a type of mutant that contains less than 
the normal amount of gene product.  In the aldicarb assay, the snt-1 single mutant showed 
a slight resistance to aldicarb. The snt-1; zf35 double mutant and the wild-type responded 
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similarly to aldicarb. Based on the aldicarb data, zf35 restores snt-1 to N2 like sensitivity 
to aldicarb. This meant that there was some interaction between the genes. This suggests 
that there is an interaction between zf35 and snt-1, possible function in the same pathway.  
 
 
Figure 19: snt-1; zf35 Double Mutant Aldicarb Assay. Aldicarb assays were performed on 1 mM NGM 
Aldicarb plates using 20 worms. Worms were assayed until 100% paralysis was seen. Paralysis is defined 
as lack of movement in response to an anterior and posterior touch with a platinum pick. 
 
unc-13 worms are paralyzed. unc-13 worms have abnormalities in pharyngeal 
pumping, axon morphology, protein sub cellular localization, and ectopic axon outgrowth 
(WormBase, 2008). unc-13 is part of the pathway that uses synaptic vesicles for 
neurotransmission. In the aldicarb assay (Figure 20) the unc-13 single mutant showed 
hyper-sensitivity to aldicarb similar to zf35. The unc-13; zf35 double mutant and the N2 
wild-type strain responded similarly to aldicarb. The formation of the double mutant with 
unc-13 causes resistance towards aldicarb to increase and correspond with the N2 
sensitivity. This means that unc-13 did interact with zf35, and a possible mutant rescue 
might have taken place. Such an event was possible because the sensitivity of zf35 was 
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not evident in the double mutant (WormBase, 2008).  unc-13 worms appeared 
hypersensitive as a result of their general locomotion defects. unc-13 appeared to be 
paralyzed even in the absence of aldicarb. However, according to Richmond et al., unc-
13 worms are resistant to aldicarb.  
 
Figure 20: unc-13; zf35 Double Mutant Aldicarb Assay. Aldicarb assays were performed on 1mM NGM 
Aldicarb plates using 20 worms. Worms were assayed until 100% paralysis was seen. Paralysis is defined 
as lack of movement in response to an anterior and posterior touch with a platinum pick. 
 
unc-31 worms are slow moving, recessive, and mate poorly. The aldicarb assay 
done on the unc-31 single mutant showed sensitivity to aldicarb similar to the wild-type 
N2 (Figure 21). The unc-31; zf35 double mutant and the zf35 strain responded similarly 
to aldicarb. No evidence of suppression or interaction was observed since the double 
mutant looked the same as the single mutant. The unc-31 mutation acts in the pathway 
that uses dense core vesicles for synaptic transmission. unc-31 looks wild-type on 
aldicarb because acetylcholine is released by synaptic vesicles and not released by dense 
core vesicles.  
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Figure 21: unc-31; zf35 Double Mutant Aldicarb Assay. Aldicarb assays were performed on 1mM NGM 
Aldicarb plates using 20 worms. Worms were assayed until 100% paralysis was seen. Paralysis is defined 
as lack of movement in response to an anterior and posterior touch with a platinum pick. 
 
egl-30 is an egg laying deficient mutant. It is a loss of function mutation that 
results in the excessive production of DAG and thus more acetylcholine is released than 
necessary. egl-30 loss of function mutation up regulates the GαQ pathway resulting in an 
overproduction of DAG. DAG leads to the activation of the UNC-13 (priming factor). 
This results in an increase in acetylcholine release (Reynolds et al., 2005).  In the aldicarb 
assay (Figure 22), the egl-30 single mutant showed sensitivity to aldicarb similar to the 
wild-type. Evidence of suppression in egl-30;zf35 mutant worms was observed through 
phenotype assessment but not through the analysis of the aldicarb assay data. However, 
we were not sure if the egl-30;zf35 carries the egl-30 allele. egl-30;zf35 mutant worms 
showed locomotion similar to wild-type worms. These double mutants were unlike the 
paralyzed egl-30 worms or the hyperactive zf35 worms. Suppression would mean that 
there is some form of interaction between egl-30 and zf35. Similar to unc-13, egl-30 
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worms also indicated hypersensitivity to aldicarb as a result of their general locomotion 
defects. Like unc-13, egl-30 worms also appeared to paralyzed. However, according to 
Reynolds et al., egl-30 worms are resistant to aldicarb. 
 
 
Figure 22: egl-30; zf35 Double Mutant Aldicarb Assay. Aldicarb assays were performed on 1mM NGM 
Aldicarb plates using 20 worms. Worms were assayed until 100% paralysis was seen. Paralysis is defined 
as lack of movement in response to an anterior and posterior touch with a platinum pick. 
 
Aldicarb and Levamisole assays were performed on the mutants derived from the 
EMS mutagenesis (Table I).  zf88, zf62, and zf65 were selected for complementation tests 
because of the uncoordinated locomotion observed. Three distinct mutants were selected 
from the genetic screen based on their sensitivity to aldicarb and levamisole. zf88 was 
selected for being presynaptic because it was observed to be resistant to aldicarb and 
showed wild-type response to levamisole.  This meant that either not enough 
acetylcholine was produced in zf88 worms or there were other problems within the 
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presynaptic pathway. zf62 and zf65 were chosen because they were both resistant to 
aldicarb and levamisole.  
 
Table 1: Summary of EMS Mutant Screening. The legends shows the how the mutants were 
characterized relative to their sensitivity to aldicarb and levamisole. Mutants from this procedure had 
aldicarb and levamisole assays performed on them to determine whether presynaptic or post-synaptic 
acetylcholine function was altered. The data from these assays is listed in table 1. For each mutant, 20 
worms were placed on 1mM aldicarb NGM agar plates for 1 hour. In addition, 20 worms were also placed 
on 100uM levamisole NGM agar plates for 3 hours. At the end of the assays, the percentage of worms 
moving was recorded for each assay.  
 
The mutagenesis was done in the zf35 lon-2 background. To further characterize 
these mutations it was necessary to separate them from the zf35 lon-2 background. To do 
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this (zf62, zf65, and zf88); zf35 lon-2 animals were crossed with wild-type ♂. The cross 
used to achieve this goal is shown in figure 23. The wild type males were crossed with 
(zf62, zf65, and zf88); zf35 lon-2 hermaphrodites.  In the F1 generation, cross progeny 
were picked and selfed.  In the F2 generation, non lon worms exhibiting the unc 
phenotype were picked and selfed. In the F3 generation, non lon worms were picked.
 
Figure 23: Scheme to Phase Out zf35-lon2. The cross was designed to remove the zf35 lon-2 background 
from the EMS mutants selected for complementation . 
 
SNP mapping was used to map the EMS mutants to the chromosome they were 
linked to. Figure 24a shows the chromosome I SNP gel for zf62 using the listed primer 
pairs in figure 24b. The mutant DNA should look identical in band position and intensity 
to the 50:50 N2/CB4856 mix if there is no linkage to the chromosome. However, if there 
is linkage, the N2 band is enriched, and the intensity of the CB4856 band is decreased 
when compared to N2/CB4856 mix. 
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For the zf62 mutant, linkage was predominantly found between the SNPs at -6 to 
+5 on chromosome I, suggesting that zf62 is linked to chromosome I.  
A 
 
 
 
Figure 24: SNP Mapping of zf62. 
(A) Chromosome I SNP gel of zf62. 
The region with the highest linkage is 
highlighted with the red box.   (B) 
SNPs used for the mapping of 
Chromosome I of zf62. 
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A similar method was used to interpret the zf65 and zf88 SNP gels. Figure 25a 
shows the chromosome I SNP gel of zf65. The strongest linkage can be seen at the 
interval -6 to +13 on chromosome I.   
 
A 
 
Figure 25: SNP Mapping of zf65. 
A) Chromosome I SNP gel of zf65. 
The region with the highest linkage 
is highlighted with the red box.   (B) 
SNPs used for the mapping of 
Chromosome I of zf65. 
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As seen in figure 26a, the strongest linkage for zf88 can be seen at the interval +1 
to +18 on chromosome V.  
A  
Figure 26: SNP Mapping of 
zf88. A) Chromosome I SNP gel 
of zf88. The region with the 
highest linkage is highlighted 
with the red box.   (B) SNPs 
used for the mapping of 
Chromosome I of zf88. 
 
 
B 
 
 
Once the three mutants were mapped to their respective chromosomes, the 
interval was further narrowed down narrow using fine mapping. The concept behind this 
specific version of fine mapping is that the closer one gets to the mutation, the lesser the 
chance for recombination to occur. Thus seeing an enrichment of N2 would indicate that 
one is in close proximity to the mutation. The further away one is from the mutation, the 
more the chance for a recombination event to occur. 
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The fine mapping gel for zf62 can be seen in Figure 27. Table 2 shows the 
complete fine mapping data for zf62. Figure 27a shows the left boundary at -3.14 and 
figure 27b shows the right boundary at +2.94.  
 
Table 2: Fine Mapping Data for zf62. As one gets closer to the mutation, N2 enrichment is observed and 
the number of heterozygotes decreases. The left and right boundaries are determined by the transition from 
heterozygous (het) to N2. The boundaries are established where a minimal number of heterozygous (het) 
are seen at the point of transition.      
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Figure 27a: Left Boundary Fine Mapping Gel of 
zf62. The locus was -3.14 and HinfI is used as the 
restriction enzyme The primers used were 5' primer 
= TTTTGGCTCCAAGGGTCACTC and 3' primer 
= CGAATGTTTGTTGAAAAAGCGG. 
Figure 27b: Right Boundary Fine Mapping Gel 
of zf62. The locus was +2.94 and DraI is used as the 
restriction enzyme The primers used were 5' primer 
= TTCAGGCTCCACTTTATGCC and 3' primer = 
CATCTGGGACGTTCTTTCAC. 
 
 
 The fine mapping gel for zf65 can be seen in figure 28. Table 3 shows the 
complete fine mapping data for zf65. Figure 28a shows the left boundary at -1.67 and 
figure 28b shows the right boundary at +0.06.  
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Table 3: Fine Mapping Data for zf65. As one gets closer to the mutation, N2 enrichment is observed and 
the number of heterozygotes decreases. The left and right boundaries are determined by the transition from 
heterozygous (het) to N2. The boundaries are established where a minimal number of heterozygous (het) 
are seen at the point of transition.      
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Figure 28a: Left Boundary Fine Mapping Gel 
of zf65. The locus was -1.67 and ClaI is used as 
the restriction enzyme The primers used were 5' 
primer = GTGAACGTCGTGATGAGGAG and  
3' primer = TGAAGTGGTCCCGAATATATG. 
 
Figure 28b: Right Boundary Fine Mapping 
Gel of zf65. The locus was +0.06 and AvaI is 
used as the restriction enzyme The primers used 
were 5' primer = 
AATTCCGATGATGGAGACGG and  
3' primer = GGTTACCATTCCAAATAGTGC. 
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The fine mapping gel for zf88 can be seen in figure 29. Table 4 shows the 
complete fine mapping data for zf88. Figure 29a shows the left boundary at +23.25 and 
figure 29b shows the right boundary at +24.99. 
 
Table 4: Fine Mapping Data for zf88. As one gets closer to the mutation, N2 enrichment is observed and 
the number of heterozygotes decreases. The left and right boundaries are determined by the transition from 
heterozygous (het) to N2. The boundaries are established where a minimal number of heterozygous (het) 
are seen at the point of transition.      
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Figure 29a: Left Boundary Fine Mapping Gel of zf88. The 
locus was +23.25 and Tsp509I is used as the restriction enzyme 
The primers used were 5' primer = 
GACTTTTCGGATTGTCCATCAG and  
3' primer = GACACTTACCGATATGCCGC. 
Figure 29b: Right Boundary Fine 
Mapping Gel of zf88: The locus was 
+24.99 and AccI is used as the 
restriction enzyme The primers used 
were 5' primer 
=CCCTCAATCTTGCCCCATTC and  
3' primer 
=AATGACGGGCAACTTTCAGG. 
 
 
The fine mapping data was used to narrow down the genetic intervals in which the 
mutations lie. Once the intervals were narrowed down, we looked for candidate genes 
that acted presynaptically or might influence a calcium channel. For the intervals -1.67 to 
0.06 and -3.14 to 2.94, unc-63 was a likely mutant that fit these characteristics that zf62 
and zf65 exhibits. zf62 and zf65 are postsynaptic according to the aldicarb assays done on 
them.   unc-63 is also postsynaptic.  
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The alpha subunit of the nicotinic acetylcholine receptor (nAChR) is encoded by 
unc-63. unc-63 is expressed in many neurons, vulval muscles, and body wall muscles of 
C. elegans.  unc-63 is required for regular egg laying behavior and locomotion. The alpha 
subunit of a nicotinic acetylcholine receptor is encoded by unc-63. Functionally, unc-63 
acts as a ligand-gated ion channel that controls acetylcholine release at neuromuscular 
junctions (WormBase, 2008).  Figures 30 and 31 show the fine mapped intervals of zf62 
and zf65 respectively. In both cases, unc-63 was selected for a complementation test.  
 
                         Figure 30: Known uncs Between the Loci -1.67 and +0.06 on Chromosome I. 
 
 
 
                            Figure 31: Known uncs Between the Loci -3.14 and +2.94 on Chromosome I. 
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unc-51 is a presynaptic gene that encodes a serine/threonine protein kinase. The 
axons that are located along the anterior-posterior axis require this protein kinase for 
regular outgrowth.  unc-51 is expressed in all neurons, pharyngeal muscles, and body 
wall muscles of C. elegans (WormBase, 2008). Figure 32 shows the fine mapped 
intervals of zf88.  unc-51 was selected for complementation since it was a uncoordinated 
presynaptic mutant in the interval.  
 
                     Figure 32: Known uncs Between the Loci +23.25 and +24.99 on Chromosome V. 
 
The complementation test for zf62 and zf65 was performed using the cross in 
figure 33. For the mapped intervals of zf62 and zf65, unc-63 was chosen as a likely 
candidate based on the similarity of the phenotypes. Based on the results from the 
complementation test, both zf62 and zf65 failed to complement unc-63. Therefore, zf62 
and zf65 were identified as unc-63. 
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Figure 33: zf62 & zf65 Complementation Test With unc-63. The zf62 & zf65 mutants failed to 
complement with unc-63. Hence, zf62&zf65 were identified as unc-63. 
 
The complementation test for zf88 was performed using the cross in figure 34. For 
the mapped intervals of zf88, unc-51 was chosen as the most likely candidate based on 
the similarity of the phenotypes. Based on the results from the complementation test, zf88 
complemented unc-51. Hence, zf88 was not unc-51. Note that rol-9 was a genetic marker 
that did not influence the complementation test results. 
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Figure 34: zf88 Complementation Test With unc-51.  The zf88 mutant successfully complemented with 
unc-51. Hence, zf88 was not identified as unc-51. 
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DISCUSSION 
 
 
zf35 is a presynaptic gain of function mutant that displays genetic dominance and 
hyperactivity. These unique sets of characteristics make it a rare mutation. The sensitivity 
to aldicarb and the wild-type response to levamisole implied that zf35 was a presynaptic 
hyperactive mutation with a defect causing an increase in acetylcholine at the synapse. 
Through fine mapping using SNPs, zf35 was identified as an allele of the unc-2 gene.  
unc-2 encodes the alpha-1 subunit of a P/Q type calcium channel, similar to the 
mammalian CACNA1A. The P/Q type calcium channels are important for successful 
synaptic transmission. Previous research has implicated mutations of Familial hemiplegic 
migraines (FHM) and autism. 
C. elegans UNC-2 is homologous to the CACNA1H channel in humans, a T-type 
CaV3.2 calcium channel. The electrophysiological, electrochemical, and biochemical 
data presented by Splawski et al. (2006) suggests that various combination of mutations 
present in the CACNA1H channel may play a role in Autism spectrum disorders. Autism 
is a neurological disease that affects brain development and neuronal function in humans. 
Symptoms include problems with communication, social interaction and restrictive and 
repetitive behavior. Splawski et al. identified 6 missense mutations in a conserved region 
of CACNA1H in patients that exhibited symptoms of autism. Splawski et al. concluded 
that these mutations reduced calcium channel activity and suggested that this could 
impact proper brain development and neuron function leading to Autism spectrum 
disorder (Splawski et al., 2006). 
Familial Hemiplegic Migraine is an autosomal dominant disorder that is 
associated with mutations in the CACNA1A calcium channel.  Many of the symptoms of 
 56
FHM such as intense headaches, intolerance of loud sounds, and intolerance of intense 
light, are similar to those of a classic migraine. FHM is unique relative to classic 
migraines because FHMs are the associated with auras or other transient neurologic 
symptoms. These neurological symptoms may include cerebellar atrophy, the 
degeneration of the cerebellum, and ictal hemiparesis, the paralysis and weakness in one 
side of the body. The importance of studying FHM in detail is highlighted because of the 
implications of better understanding the complex factors influencing common migraines. 
(Hans et al., 1999). Further research on the CACNA1A calcium channel in C. elegans 
may prove fruitful to fully understand these debilitating diseases, and possibly suggest 
curative measures. As unc-2 encodes the alpha-1 subunit of the CACNA1A of C. 
elegans, further analysis on this mutation may provide better understanding of these 
diseases.  
unc-2 null animals are uncoordinated, aldicarb resistant and similar to wild-type 
on levamisole and nicotine. GFP fusion, unc-2 promoter bound to GFP, has also indicated 
that unc-2 is expressed in the nervous system but not in the body wall, vulval or utrine 
muscles of C. elegans.  Behavioral and expression data implies unc-2 affects presynaptic 
neurotransmission in C. elegans nervous system (Mathews et al., 2003). To date, many of 
the mutations in C. elegans unc-2 have been loss of function mutations. zf35 is one of the 
first gain of function unc-2 alleles identified.  
To further define the pathway through which zf35 acts, epistatic analyses of 
double mutants were performed to search for suppressers. The mutants that zf35 was 
crossed with were selected because they act in synaptic release. snt-1 showed an 
interaction with zf35 based on the aldicarb assay data. snt-1 is resistant to aldicarb, and 
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according to Nguyen et al., snt-1 mutants are defective in exocytosis and accumulate 
acetylcholine in their tissues. snt-1, a partial loss of function mutant, is capable of 
coordinated motor movements demonstrating that it does not have a complete block in 
acetylcholine release (Nguyen et al.,1995).  
These observations suggest that snt-1 restores the zf35 mutant to wild-type 
because there is a decreased rate of neurotransmitter release caused by snt-1. This 
compensates for excessive release of acetylcholine by zf35. According to Richmond et al. 
(1999), unc-13 worms are also resistant to aldicarb. unc-13 is involved in the priming of 
vesicles and is required for synaptic vesicle exocytosis (Richmond et al., 1999). A 
problem in priming or exocytosis should cause less acetylcholine to be released even if a 
substantial increase in calcium occurs. In the case of the double mutant unc-13; zf35, the 
aldicarb data suggests that there is no significant change acetylcholine release even with 
the increased calcium influx caused by the zf35 gain of function. The aldicarb sensitivity 
of unc-31 worms is similar to wild-type. Acetylcholine is released by synaptic vesicles 
and not released by dense core vesicles. Because dense core vesicles are important in 
neurotransmitter release in the synaptic pathway in which unc-31 acts in, acetylcholine 
release is unaffected in the unc-31 mutants. Therefore, unc-31 worms show wild-type 
sensitivity to aldicarb (Charlie et al., 2006).    
egl-30 loss of function mutants are paralyzed in the absence of aldicarb. The g-
alpha-q pathway is required for synaptic transmission and does not function properly in 
egl-30 mutants.  As a result, egl-30 worms only release a small amount of 
neurotransmitter.  Aldicarb does not drastically alter egl-30’s paralyzed state; however, it 
causes a slight rescue of paralysis. Since aldicarb causes a buildup of acetylcholine in the 
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synaptic cleft, egl-30 was observed as a phenotypic suppressor of zf35.  However, it was 
necessary to confirm whether animals isolated from the egl-30 and zf35 cross contained 
mutant alleles of both genes. Furthermore, a balancer is necessary to confirm whether the 
egl-30 allele exists in the resulting double mutant (Reynolds et al., 2005).  
A genetic suppressor screen was performed by mutagenizing zf35 which resulted 
in the isolation of 40 mutants. These 40 mutants were further characterized on aldicarb 
and levamisole plates, and 3 distinct mutants were picked for further study: zf62, zf65, 
and zf88.  The zf88 mutant was determined to function presynaptically due to the results 
of the aldicarb and levamisole assays. zf88 was mapped between +23.25 and +24.99 on 
chromosome V, and unc-51 was chosen as a candidate gene because unc-51 is an 
uncoordinated presynaptic mutant (WormBase, 2008). A complementation test with unc-
51 resulted in a successful complementation; therefore zf88 is not an allele of unc-51. 
There are however, other candidate genes within the mapped interval on chromosome V.  
ncx-1 was identified as a gene of interest because it is thought to play a critical role in 
neuronal Ca2+ homeostasis and function (Zamponi, 2005). ncx-1 is a Na+/ Ca2+ exchanger 
that is highly expressed in areas of high plasmalemmal Ca2+ flux, such as presynaptic 
terminals (Lytton, 2007) . The function of this exchanger in neurons is to extrude Ca2+ 
following its entry, thus terminating signaling events and restoring homeostasis for the 
next round of signaling.     
Future experiments could include performing patch-clamp recordings on Xenopus 
oocytes, balancer confirmation of the egl-30 double mutant, fully characterizing every 
mutant derived from the EMS screen, creating double mutants with additional genes 
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involved in synaptic transmission, and sequencing the zf88 mutant to determine if zf88 is 
ncx-1. 
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